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In a previous communication one of us (L. G.) (1) has reported the feeding
of soybean lecithin mixtures to be of value in some cases of psoriasis. Soybean
lecithin was used because of the lipotropic character of the lecithin, and the fact
that soybean lecithin was so easily available. This mixture is stable and is
reported to contain lecithin 20%, cephalin 20%, oil 30%, phytosterols 2%,
inositol and allied compounds 15%, and carbohydrates 10%. Inositol is also a
lipotropic substance. Since that report some 16 additional patients have been
treated for varying periods of time with improvement in approximately 60%
of them. In most instances the patients receiving the lecithin were also on a
fat poor diet. These patients received no vitamin mixtures in addition to the
lecithin, although supplementation of lecithin therapy with vitamin B com-
plex has been suggested for those patients who do not respond to simple
lecithin feeding. There were no reactions to this soybean lecithin. Gross and
Kesten (2), and Sullivan and Nicholls (3) have studied the effect of lecithin in
relation to vitamin research.
In an effort to secure a better controlled study of patients with this difficult
disease and to examine, after a fashion, their metabolism of fats, five patients
with psoriasis of varying severity were observed in the hospital during lecithin
feeding. It is important to note that these patients were also on a low fat diet,
approximately 40 gms per day. At present the study has been completed on
only four patients.
The following blood lipid chemistry studies were made on these patients:
Fasting—cholesterol, cholesterol esters, and phosphatides; lipokrit index
Fat tolerance tests—using 500 cc. 20% cream with samples taken at 2, 4
8 and 12 hours and all the lipid studies repeated with each sample.
Repetition of the fat chemistry studies after 1, 2 and 4 weeks of lecithin
feeding.
Liver function tests were also made. These tests were the bromsulfalein
and the cephalin-cholesterol flocculation tests (4, 5).
For the determination of the lipids, Bloor extracts of serum were made and
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aliquots of these were used. Total cholesterol was determined as follows:
saponification in ether-alcohol followed by selective extraction first with petro-
leum-ether then chloroform. The final determinations were made color-
imetrically using the Liebermann-Burkhardt reaction with acetic anhydride
and sulphuric acid. The color was determined in an Evelyn electrophoto-
lometer using the 620 filter.
Free cholesterol was determined by extracting with petroleum ether the
residue left after evaporation of the original Bloor extract. This was subse-
quently concentrated and the phospholipids precipitated in acetone solution
by magnesium chloride. The precipitate was used for phospholipid P deter-
minations and the supernatant fluid was collected quantitatively with rinsing.
After concentration of this acetone solution free cholesterol was precipitated
by means of digitonin. This precipitate was freed from interferring substances
by extraction with petroleum-ether after which the digitonin-cholesterol com-
plex was dissociated by boiling benzene. The benzene extract was concen-
trated and freed of digitonin by successive treatments with petroleum-ether.
This extract was then worked up in the same fashion as that for the cholesterol
determination.
The phospholipid precipitate was digested with sulphuric acid and hydrogen
peroxide in the usual fashion. The P was determined colorimetrically by a
modification of the Fiske-Subbarow method using the Evelyn photolometer
with the 660 filter.
All $amples were run in duplicate and, if satisfactory tests were not obtained,
additional determinations were made. All determinations were run with several
standards and the K value determined for each set of determinations.
The lipokrit method (6) is essentially a simple volumetric micromethod for
the determination of lipids modified after the Hemolipokrit method of Ruckert.
Freshly prepared special reagent of methylene blue sulphuric acid—Scharlach-R
amyl alcohol was mixed with serum in the special Iipokrit pipette and shaken
and then centrifuged and readings were taken in 30 minutes and after 24 hours
of hydrolysis. The 30 minute reading is supposed to represent neutral fats,
fatty acids, cholesterol, and cholesterol esters. The 24 hours reading is supposed
to indicate cerebrosides and phosphatides.
It is realized, of course, how difficult it is to interpret studies of fat metabolism
as related to psoriasis. In 11 cholesterol determinations on 9 eases of psoriasis
Strickler and Adams (7) reported 4 cases above 170 mgs. and 7 normal. In an
extensive study of 35 cases of psoriasis Rosen and Krasnow (8) reported an
average cholesterol of 165 13, an average lecithin of 248 16. With rgard
to cholesterol these investigators had 29% of their cases below 171 16 mgs.,
63% within 171 16 mgs., and 9% above 171 16 mgs. With regard to
lecithin, 9% were below 242 22, 66% within 242 22, and 25% above 242
22. Montgomery (9) has indicated recently the lack of uniformity of cholesterol
determinations in patients with psoriasis. Fat tolerance tests were done also in
10 patients with psoriasis by LeWinn and Zugerman and normal results were
obtained, as indicated by the changes in the total cholesterol content of whole
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CHART OF LIPOKRIT READINGS
blood. There have been criticisms of the fat tolerance tests used at the present
time, either the test with the 20% cream or the olive oil-cholesterol mixture,
but there are no other practical clinical measures available at present for the
study of fat metabolism.
= fasting serum; 2 = 2 hours after fat meal; 4 = 4 hours after fat meal; 8 = 8 hours
after fat meal; 12 = 12hours after fat meal.
130 MINUTEWEEE PATIENT RJIADRiG
TOTAL I WEEELIPIDS PATIENT
3OMINUTE
READING
TOTAL
LIPIDS
Before lecithin N. M. 0* 100
feeding N. M. 2 .040
N.M.4 .390
N.M.8 .200
First week with N.M. 0 .160
lecithin feed- N. M. 2 .560
ing N.M.4
N.M.8
N. M. 12
:700
.660
.280
Fourth week N. M. 0 .160
with lecithin N. M. 2 .440
feeding N. M. 4
N.M.8
N. M. 12
.590
.680
.530
Before lecithin A. K. 0 .090
feeding A. K. 2
A.K.4
.070
.110
First week with A. K. 0 .380
lecithin feed- A. K. 2 .400
ing A. K. 4
A.K.8
A. K. 12
.320
.240
.160
Fourth week A. K. 0 .220
with lecithin A. K. 2 .530
feeding A. K. 4
A.K.8
A. K. 12
.560
.460
.460
Before lecithin A. B. 0 .060
feeding A. B. 2
A. B. 4
A. B. 8
.120
.360
.260
.544
.904
1.602
1.072
1.072
.992
1.012
1.008
.400
256
.536
.866
1.220
.998
.246
.426
.674
.452
556
1.136
1.200
1.036
.604
.638
.572
.484
.460
.276
.264
.360
.452
Before lecithin
feeding
First week with
lecithin feed-
ing
Fourth week
with lecithin
feeding
Before lecithin
feeding
First week with
lecithin feed-
Fourth week
with lecithin
feeding
First week with
lecithin feed-
ing
M. H. 0
M. H. 2
M. H. 4
M. II. 8
M. II. 12
M. 11.0
M. H. 2
M. H. 4
M. 11.8
M. II. 12
M. 11. 0
M. 11. 2
M. 11. 4
M. H. 8
M. H. 12
C. Y. 0
C. Y. 2
C. Y. 4
C. Y. 8
C. Y. 12
C. Y. 0
C. Y. 2
C. Y. 4
C. Y. 8
C. Y. 12
C. Y. 0
C. Y. 2
C. Y. 4
C. Y. 8
C. Y. 12
A. B. 0
A. B. 2
A. B. 4
A. B. 8
A. B. 12
.200
290
.670
.350
.150
.170
.460
.360
.190
.200
520
.560
.500
.120
.610
.500
.830
.740
.610
.420
640
.760
.600
.280
.840
.760
1.020
1.160
.640
.280
.120
.300
.320
.240
1.134
1.094
1.426
1.106
.594
.674
724
.384
.622
.824
1.048
1.282
1.292
.768
1.246
1.364
1.610
1.940
1.126
1.188
1.744
1.840
1.656
1.528
1.104
1.144
1.308
1.304
.976
.352
.360
.468
344
.288
324 TRE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Because of the confusion of the different reports regarding cholesterol levels
an effort was made to see whether disturbances existed in the interrelationships
of the different lipid components. So, the ratios which Schaaf (10) proposed
for xanthoma were employed in these selected cases of psoriasis.
mg. % combined cholesterol = A = 2.0 average
mg. % free cholesterol
mg. % phosphatide — P X molecular weight of cholesterol B 2.0 average
mg. % free cholesterol X atomic weight of P
mg. % combined cholesterol X atomic weight of P = A/B — — 1 0 av
mg. % phosphatide — P X molecular weight of cholesterol
I 0.00
Fia. 1. LIPoREIT READINGS DURING A FAT TOLERANCE TEST ON A PSORIASIS CASE
Patient N.M. Age 39
Schaaf believed that "as long as there are no qualitative changes in the ratio,
quantitative changes of the individual fats and lipoids may then occur without
causing any damage." Such ratios were determined on the cases of psoriasis in
conjunction with the so-called fat tolerance test. In their work on lipocaic and
psoriasis, Clark, Dragstedt, Walsh and Becker (11) measured total fasting blood
serum lipids.
There are wide variations for the figures. of normal lipoid substances in the
blood. In many instances there is chiefly a question of technic. Weidman and
Sunderman (12) indicated this in 1925. Their cholesterol figure for man was
160—80. Montgomery and Osterberg's (13) figures for normal lipid levels for
man were total chOlesterol 180, cholesterol esters 125, lecithin 225, fatty acids
345, total lipids 525.
Sullivan and Fershtand (14) used the lipokrit volumetric method in studying
2.00
24 ER. RE.DING
0.50
30 MIN • READING
0 2 4 8 12
TIME IN ROURS
ANALYSES OF THE LIPID FRACTIONS OF THE SERA OF FOUR PSORIASIS
PATIENTS BEFORE AND DURING TWO FAT TOLERANCE TESTS
(First tolerance before lecithin feeding; "3"—after 3rd week of lecithin feeding)
PATIENT AN])
TIME
CHOLESTEROL
PHOSPHOLIPID
PHOSPHORUS
RATIO OS EMULSISYING AGENTS
Total Free A* Bt C
mgm. % mgm. % mgm. %
N. M. 0 247 70 7.0 3.52 1.25 2.83
N.M.2 280 73 3.84
N. M. 4 292 85 3.44
N.M.8 305 73 4.18
N. M. 12 274 59 4.68
N.3M.0 155 70 7.0 2.22 1.25 1.78
N.3M.2 200 74 6.6 2.70 1.11 2.43
N.3M.4 220 65 8.7 3.39 1.67 2.04
N.3M.8 213 110 9.5 1.94 1.08 1.81
N.3M.12 206 90 8.8 2.29 1.22 1.88
M.H.0 260 68 9.1 3.82 1.66 2.31
M.H.2 270 86 10.6 3.14 1.54 2.04
M.H.4 280 90 11.6 3.12 1.61 1.94
M.H.8 292 80 11.8 3.65 1.84 1.99
M.H.12 220 60 9.5 3.67 1.97 1.86
M.311.0 250 63 9.3 3.98 1.84 2.14
M.311.2 241 62 9.3 3.90 1.86 2.10
M.3H.4 230 75 8.8 3.06 1.46 2.10
M.3H.8 260 75 11.5 3.46 1.91 1.86
M. 3 H. 12 243 80 11.0 3.04 1.71 1.78
A.K.0 198 72 6.0 2.76 1.04 2.66
A.K.2 197 75 8.4 2.62 1.39 1.88
A.K.4 175 83 8.5 2.11 1.28 1.64
A. K. 8 179 90 7.5 1.98 1.04 1.91
A. K. 12 209 66 6.0 3.16 1.13 2.79
A.3K.0 176 70 8.0 2.52 1.42 1.77
A.3K.2 183 66 8.2 2.78 1.54 1.87
A.3K.4 175 58 8.5 3.02 1.83 1.65
A.3K.8 190 71 8.8 2.68 1.54 1.73
A.3K.12 195 75 9.1 2.6Q 1.50 1.73
C.Y.0 433 95 14.2 4.54 1.86 2.44
C.Y.2 294 115 11.6 2.55 1.26 2.03
C.Y.4 300 93 14.5 3.22 1.94 1.66
C. Y. 8 370 106 13.5 3.49 1.59 2.20
C.Y.12 315 99 12.1 3.18 1.52 2.09
C.3Y.0 450 73 150 6.15 2.56 2.40
C.3Y.2 390 78 14.1 5.01 2.24 2.22
C.3Y.4 355 80 15.6 4.44 2.43 1.83
C. 3 Y. 8 387 14.4
C. 3 Y. 12 368 59 12.5 6.24 2.64 2.36
mgm. % total cholesterol*Ratip A =
mgm. % free cholesterol
mgm. % phospholipid phosphorus X mol. wt. of cholesterol
t Ratio B
mgm. % free cholesterol X atomic wt. of phosphorus
—
mgm. % total cholesterol X atomic wt. of phosphorus
—
ARatio C 
mgm. % phospholipid phosphorus X mol. wt. of cholesterol — B
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CLINICAL SUMMARIES
LIVER EUNCTION AMOUNT
DORA- _____________ LEd-
-
TION Or TYPE OP PREVIOUS THIN DURATION OP CLINICALNAME AGE PSORIA- PSORIASIS Bromo- ep a- TREATMENT MIX- PEEDING RESULT
sIs suiph- TORE
thalein DAILY
years grams
A. K. 54 25 Extensive 0 0 All types 12 4 weeks Much im-
plaque, save x- control- proved
annular ray led, 6
and gut- weeks
tate, all total
infiltrat-
ed on
body and
on scalp
lesions of
discreet
type
N. M. 39 2 Plaque, an- 0 0 All types 12 4 weeks Much im-
nular and save x- control- proved
guttate, ray led, 6
all infil-. weeks
trated total
C. Y. 36 10 Guttate on 0 0 SeIf-medi- 12 4 weeks No signifi-
trunk cation control- cant
and dii- only pro- led change
fusely on prietory
scalp
M. H. 52 32 Plaque on 0 0 Reactions 12 4 weeks No signifi-
trunk, with coitrol- cant
guttate strong led, 6 change
on ex- local weeks
tremities medica- total
diffuse tions. 6
sclpin- weeks of
volv- bed rest
ment. with ex-
Had pre- foliative
vious ex- phase
foliative
reaction
two years
ago
A. B. 11 Papular * * Lecithin 5 12 4 weeks Improved
placque- months control-
like en- ago im- led
tire body proved
diffuse remark-
pityria- ably
sis scalp flared
when dis-
con-
tinued
* Not done.
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fat absorption in normal and pathological cases. They found the average fast-
ing lipokrit level of 43 normal young men to be 0.576%. McGrath (15) study-
ing the fasting lipokrit of 100 essentially normal hospital patients has found
values varying from 0.120 to 0.680% with a mean value of 0.346%. Those
patients with fasting lipokrit levels falling within the normal range improved
(N. M., A. K., and A. B.). Those patients with abnormally high initial fasting
lipokrit levels did not (M. H. and C. Y.). The lipokrit values for the fat toler-
ance curves cannot be interpreted in this study because no control fat tolerance
curves are available as yet.
In a general manner, the cholesterol, cholesterol esters, and phosphatides
paralleled the lipokrit for each patient. If this continues to be true, the lipokrit
is a much simpler test to carry out.
Also, from these very few preliminary studies there seem to be marked changes
from normal in the lipid ratios of Schaaf. This would suggest that this particular
phase of fat metabolism, (stability of emulsions?) is disturbed in psoriasis as it
may be in xanthomatosis. Further work must be done on this, especially as
regards the "A" ratios.
We do not know at present from our figures on these few patients whether a
fat tolerance study is of any more help than a study simply of the fasting serum.
When a fat tolerance test will be standardized this question will be answered.
From these few patients it is evident that those patients with a relatively low
blood lipid level responded better to lecithin feeding than those patients with
initial high lipid levels. This has been noted before with lipocaic. It would
seem the lecithin feeding in spite of improvement, had no appreciable effect on
the lipid levels. An effort will be made to attempt to lower the blood lipids of
the resistant individuals and then to determine if these individuals will respond
to lecithin therapy. Thyroid may serve to help lower the lipid level. It is
possible also that those patients with a lower phospholipid level also improved
under lecithin therapy. In most instances the free cholesterol did not change a
great deal.
From a period of at least six weeks (in case B 3 weeks) observation it was seen
that three of the patients improved with lecithin feeding. Patient B had im-
proved some weeks previously and then relapsed when the lecithin was dis-
continued. This is in accord with our previous experiences with lecithin. In
this instance, however, the patients were hospitalized and kept wider more rigid
control with only boric ointment used from time to time. In this study also,
the patients were kept on a fat poor diet. In our next control series a regular
diet will be used. However, it is our impression at present that lecithin is more
effective when the patient is on a fat poor diet.
CONCLUSIONS
1. A method for studying the fat metabolism of patients with psoriasis is
presented. This study included: 1) Determinations of cholesterol, cholesterol
esters, and phosphatides and consequently the lipid ratios of Schaaf in conjunc-
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tion with fat tolerance tests. 2) Lipokrit index. 3) Liver function tests
including the cephalin-cholesterol flocculation test.
2. A study was started of the effect of soybean lecithin feeding on the lipid
levels in five patients with psoriasis of varying severity. These patients were
observed in the hospital and were on a fat poor diet at the same time. From the
studies completed at present, in spite of improvement of the patients under leci-
thin feeding there was no marked change in the lipid levels, and no definite
changes in the abnormal lipid ratios. Those three patients who had relatively
low lipid levels improved under lecithin feeding while those two patients with
relatively high lipid levels did not improve under the lecithin. Further studies
are needed to clarify these findings. Similar experiences have been recorded
before with lipocaic.
The lipokrit determinations and curves were done by Ruth Hazlewood, B.A.,
in the laboratory of Dr. Edward J. McGrath of the Department of Surgery of
the Cincinnati General Hospital.
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DISCUSSION
DR. PAUL GRoss, New York, N. Y.: Dr. Goldman referred to the work on certain lipo-
tropic substances in the treatment of Psoriasis, which Dr. Kesten and I presented at the
Meeting of the American Academy of Dermatology in December 1941. We are interested
in the results reported here since we have carried on a similar investigation.
The statement of Dr. Goldman that soyabean lecithin is a substitute for lipocaic, requires
further clarification. The recent reports on the effect of lipocaic in depancreatized dogs,
show that its action differs from that of inositol and choline. The so-called soyabean
lecithin is a mixture of cephalin, containing inositol, and lecithin, containing choline.
Nevertheless, we have found that a defatted wheat germ, which is a good source of inositol
and its esters, and contains the entire Vitamin B Complex plus minerals, has a therapeutic
effect on psoriasis similar to that of soyabean lecithin. This, despite the fact that defatted
wheat germ is practically free of choline. In the action on high serum cholesterol, the
soyabean lecithin is more effective than the wheat germ. Further studies are necessary to
explain these facts, but we should not view a normal serum cholesterol as absolute evidence
of a normal fat metabolism.
DR. ARTHUR C. CURTIs, Ann Arbor, Michigan: I think Dr. Gross made a mistake when he
said I had done extensive work on fat metabolism with psoriasis. I have followed about
twenty patients with psoriasis on lecithin feeding, with my interest directed more toward
the disturbance in fat metabolism and its changes on such a regimen than upon the involu-
tion of the psoriasis lesions.
In these patients, the cholesterol values were usually elevated but the total blood lipids
were either normal or only slightly abnormal. The spread of fat, cholesterol, and phos-
pholipid levels were so little changed, compared to an equal number of normal people, that
we feel our figures were not significant. Diseases such as hyperthyroidism, hypothyroid-
ism and myxedema would produce similar changes.
In xanthalsma high total blood lipid levels are to be expected and were found. In some
cases we have followed, lecithin seemed to reduce the blood fat level but again we have not
followed enough cases for a long enough period to report these results as final at that time.
DR. DAVID KAHN, Chicago: Six months ago I briefly reviewed the records of 46 psoriatic
patients who had received lipocaic. The various responses to this therapy did not ppear
to be definitely correlated with changes in the total blood lipids, cholesterol, or cholesterol
esters. A more detailed study is in progress.
DR. DUDLEY C. SMITH, University, Va.: Several years ago I had the occasion to discuss
the treatment of psoriasis with a physician in general practice. He stated that he had had
four cases over the period of a number of years and had "cured them all". All of these pa-
tients had a distaste for milk and butter. He insisted that thy take lb. of butter and 1 qt.
of milk daily. I did not know how to interpret these statements because the diagnosis may
have been incorrect and psoriasis is a variable clinical condition.
Shortly after this a patient with typical psoriasis was seen in the Clinic. When asked
if he drank milk and ate butter he answered in a vigorous tone that "he never took either
in his life". The next day a physician who had been seen several times previously because
of psoriasis came in. When he was asked the same question he replied that he had never
liked nor used milk or butter. We re-examined 35 cases of psoriasis and found that about
75% of these either had a distaste for dairy products or were unable to obtain these in
adequate quantities.
Therapeutic trials with milk and butter, cod liver oil and carotene in oil caused no special
relief in any of these cases except that one was apparently cured. The high percentage of
cases though whose history indicate this deficiency would seem to be significant. Experi-
mental work similar to that reported here may lead eventually to the scientific explanation
of the above observations.
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Dn. LEON GOLDMAN, Cincinnati: Some of the work done previously in diets with psoriasis
may be correlated by the fact that the bad effects of a high protein diet certainly have some
relationshipto cholesterol metabolism.
At present, although the compounds are certainly different, lipocaic and lecithin feedings
seem to have similar effects on the fat metabolism.
However well the fat metabolism theory may sound for psoriasis, practice alone will show
its true value. "Syndrome" was used because we believe that psoriaEis is a type cutaneous
reaction of different etiologies.
